These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 22443586)

  • 21. Mechanism-based inactivation of cytochrome P450s 1A2 and 3A4 by dihydralazine in human liver microsomes.
    Masubuchi Y; Horie T
    Chem Res Toxicol; 1999 Oct; 12(10):1028-32. PubMed ID: 10525281
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanism-based inhibition of human cytochrome P450 1A1 by rhapontigenin.
    Chun YJ; Ryu SY; Jeong TC; Kim MY
    Drug Metab Dispos; 2001 Apr; 29(4 Pt 1):389-93. PubMed ID: 11259321
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of P450 1A1 and P450 1A2 in bioactivation versus detoxication of the renal carcinogen aristolochic acid I: studies in Cyp1a1-/-, Cyp1a2-/-, and Cyp1a1/1a2-/- mice.
    Arlt VM; Levová K; Bárta F; Shi Z; Evans JD; Frei E; Schmeiser HH; Nebert DW; Phillips DH; Stiborová M
    Chem Res Toxicol; 2011 Oct; 24(10):1710-9. PubMed ID: 21932800
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Application of molecular modeling for prediction of substrate specificity in cytochrome P450 1A2 mutants.
    Tu Y; Deshmukh R; Sivaneri M; Szklarz GD
    Drug Metab Dispos; 2008 Nov; 36(11):2371-80. PubMed ID: 18703643
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanism-based inactivation of cytochromes P450 2B1 and P450 2B6 by 2-phenyl-2-(1-piperidinyl)propane.
    Chun J; Kent UM; Moss RM; Sayre LM; Hollenberg PF
    Drug Metab Dispos; 2000 Aug; 28(8):905-11. PubMed ID: 10901699
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of human cytochrome P450 enzymes by 1,2-dithiole-3-thione, oltipraz and its derivatives, and sulforaphane.
    Langouët S; Furge LL; Kerriguy N; Nakamura K; Guillouzo A; Guengerich FP
    Chem Res Toxicol; 2000 Apr; 13(4):245-52. PubMed ID: 10775323
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro inhibitory effect of luotonin A on human CYP1A.
    Jahng Y; Kwon OK; Lee S
    Arch Pharm Res; 2012 Dec; 35(12):2199-203. PubMed ID: 23263815
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In silico studies of polyaromatic hydrocarbon inhibitors of cytochrome P450 enzymes 1A1, 1A2, 2A6, and 2B1.
    Sridhar J; Jin P; Liu J; Foroozesh M; Stevens CL
    Chem Res Toxicol; 2010 Mar; 23(3):600-7. PubMed ID: 20078084
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human cytochrome P450 1A1 structure and utility in understanding drug and xenobiotic metabolism.
    Walsh AA; Szklarz GD; Scott EE
    J Biol Chem; 2013 May; 288(18):12932-43. PubMed ID: 23508959
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Review of Ligand Specificity Factors for CYP1A Subfamily Enzymes from Molecular Modeling Studies Reported to-Date.
    Sridhar J; Goyal N; Liu J; Foroozesh M
    Molecules; 2017 Jul; 22(7):. PubMed ID: 28698457
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preferred binding orientations of phenacetin in CYP1A1 and CYP1A2 are associated with isoform-selective metabolism.
    Huang Q; Deshmukh RS; Ericksen SS; Tu Y; Szklarz GD
    Drug Metab Dispos; 2012 Dec; 40(12):2324-31. PubMed ID: 22949628
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Further assessment of 17alpha-ethinyl estradiol as an inhibitor of different human cytochrome P450 forms in vitro.
    Chang SY; Chen C; Yang Z; Rodrigues AD
    Drug Metab Dispos; 2009 Aug; 37(8):1667-75. PubMed ID: 19454483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The alkaloid rutaecarpine is a selective inhibitor of cytochrome P450 1A in mouse and human liver microsomes.
    Ueng YF; Jan WC; Lin LC; Chen TL; Guengerich FP; Chen CF
    Drug Metab Dispos; 2002 Mar; 30(3):349-53. PubMed ID: 11854157
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Environmentally persistent free radical-containing particulate matter competitively inhibits metabolism by cytochrome P450 1A2.
    Reed JR; dela Cruz AL; Lomnicki SM; Backes WL
    Toxicol Appl Pharmacol; 2015 Dec; 289(2):223-30. PubMed ID: 26423927
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The presence of inducible cytochrome P450 types 1A1 and 1A2 in the BeWo cell line.
    Avery ML; Meek CE; Audus KL
    Placenta; 2003 Jan; 24(1):45-52. PubMed ID: 12495659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The molecular basis for the inhibition of human cytochrome P450 1A2 by oroxylin and wogonin.
    Shao YX; Zhao P; Li Z; Liu M; Liu P; Huang M; Luo HB
    Eur Biophys J; 2012 Mar; 41(3):297-306. PubMed ID: 22228220
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanism-based inactivation of hepatic ethoxyresorufin O-dealkylation activity by naturally occurring coumarins.
    Cai Y; Baer-Dubowska W; Ashwood-Smith MJ; Ceska O; Tachibana S; DiGiovanni J
    Chem Res Toxicol; 1996 Jun; 9(4):729-36. PubMed ID: 8831817
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of starvation and chlormethiazole on cytochrome P450s of rat nasal mucosa.
    Longo V; Ingelman-Sundberg M; Amato G; Salvetti A; Gervasi PG
    Biochem Pharmacol; 2000 Jun; 59(11):1425-32. PubMed ID: 10751552
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative inhibition of human cytochromes P450 1A1 and 1A2 by flavonoids.
    Zhai S; Dai R; Friedman FK; Vestal RE
    Drug Metab Dispos; 1998 Oct; 26(10):989-92. PubMed ID: 9763404
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The binding of aristolochic acid I to the active site of human cytochromes P450 1A1 and 1A2 explains their potential to reductively activate this human carcinogen.
    Stiborová M; Sopko B; Hodek P; Frei E; Schmeiser HH; Hudecek J
    Cancer Lett; 2005 Nov; 229(2):193-204. PubMed ID: 16125300
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.